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Background: Dementia induced by β-amyloid accumulation impairs peripheral glucose homeostasis, but red
pepper extract improves glucose homeostasis. We therefore evaluated whether long-term oral consumption of
different red pepper extracts improves cognitive dysfunction and glucose homeostasis in type 2 diabetic rats with
β-amyloid-induced dementia.
Methods: Male diabetic rats received hippocampal CA1 infusions of β-amyloid (25–35) (AD) or β-amyloid (35–25,
non-plaque forming), at a rate of 3.6 nmol/day for 14 days (Non-AD). AD rats were divided into four dietary groups
receiving either 1% lyophilized 70% ethanol extracts of either low, moderate and severe pungency red peppers
(AD-LP, AD-MP, and AD-SP) or 1% dextrin (AD-CON) in Western diets (43% energy as fat).
Results: The ascending order of control < LSP <MSP and SSP potentiated the phosphorylation of CREB and GSK
and inhibited Tau phosphorylation in the hippocampus which in turn inhibited β-amyloid accumulation. The
inhibition by MP and SP reduced the memory deficit measured by passive avoidance test and water maze test.
Furthermore, the accumulation of β-amyloid induced glucose intolerance, although serum insulin levels were
elevated during the late phase of oral glucose tolerance test (OGTT). All of the red pepper extracts prevented the
glucose intolerance in AD rats. Consistent with OGTT results, during euglycemic hyperinulinemic clamp glucose
infusion rates were lower in AD-CON than Non-AD-CON with no difference in whole body glucose uptake. Hepatic
glucose output at the hyperinsulinemic state was increased in AD-CON. β-amyloid accumulation exacerbated
hepatic insulin resistance, but all red pepper extract treatments reversed the insulin resistance in AD rats.
Conclusions: The extracts of moderate and severe red peppers were found to prevent the memory deficit and
exacerbation of insulin resistance by blocking tau phosphorylation and β-amyloid accumulation in diabetic rats with
experimentally induced Alzheimer’s-like dementia. These results suggest that red pepper consumption might be an
effective intervention for preventing age-related memory deficit.
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Alzheimer’s dementia is a disease of slowly progressive
synaptic collapse in the areas of the brain underlying
memory and higher mental function [1-3]. As life expect-
ancy increases worldwide, the incidence of dementia, es-
pecially Alzheimer’s disease, has also markedly increased,
and the incidence of Alzheimer’s disease is expected to in-
crease by about 3.1 folds from 2010 to 2050 [1,2]. How-
ever, the rapid increase may not be due to increased life
expectancy alone. The increased incidence of Alzheimer’s
disease may also be related to changes in lifestyles and di-
ets such as lack of exercise and high fat and sugar diets al-
though these possible causes remain controversial [4-8].
Recent studies have shown that obesity and high-fat diets
increase the risk and/or progression of Alzheimer’s disease
in humans [9,10], and diets high in fat also increase neuro-
pathology and/or cognitive deficits in animal models of
Alzheimer’s disease [6,7]. Ongoing evidence reveals that
brain and possibly peripheral insulin resistance and con-
comitant hyperglycemia may be key metabolic dysfunc-
tions contributing to Alzheimer’s disease [8,11,12]. Thus,
it is important to identify dietary components that may
prevent or delay both Alzheimer’s disease and diabetes.
Disturbances in insulin and possibly insulin growth
factor-1 (IGF-1) signaling in the brain, especially the
hippocampus, have been observed in Alzheimer’s dis-
ease. The deletion of insulin receptor and insulin recep-
tor substrate (IRS)-2 in neurons delays brain growth
and prevents memory dysfunction in mice by the abla-
tion of the phosphoinositide-3-kinase/Akt/ mammalian
target of rapamycin (mTOR) pathway in neurons [13].
The activation of mTOR suppresses the autophagic
process in neurons and high concentrations of poten-
tially toxic β-amyloid and tau proteins are sustained in
the neurons [14]. However, by contrast, both IRS-1 and
IRS-2 expressions decrease in neurons of humans with
Alzheimer’s disease and both insulin and IGF-1 signaling
are patently disturbed in brains affected by Alzheimer’s
disease [15-17]. Type 2 diabetic patients have increased
levels of hyperphosphorylated tau in their brains that fa-
cilitate the formation of neurofibrillary tangles that induce
cognitive dysfunction [18]. Induction of experimental dia-
betes with streptozotocin or analogous drugs increases the
levels of β-amyloid and tau phosphorylation in rodents
[19,20]. Thus, the proper maintenance of insulin receptor
signaling in the hippocampus plays an important role in
cognitive function.
Due to the lack of effective treatments, it is neces-
sary to develop preventive strategies to halt the devel-
opment of Alzheimer’s disease in younger age people
prior to onset of the disease. There is also a need to
identify the environmental risk factors of Alzheimer’s
disease. The non-genetic risk factors identified from
cohort studies include caffeine consumption, lack ofexercise, stress, less education, smoking, pesticide ex-
posure and others [2,21].
Red pepper and its bioactive components such as cap-
saicinoids, capsinoids, and carotenoids are reported to
decrease body fat mass by promoting fat oxidation in
rats and humans [22,23]. Capsaicinoids, the substances
responsible for the hot pungency of peppers, are known
to induce pain by stimulating the transient receptor
potential vanilloid 1 (TRPV1), but it also paradoxically
desensitizes TRPV1 resulting in its common use in top-
ical analgesic medications [24]. Although capsaicinoid
desensitization of TRPV1 is mostly used topically, it is
also known act systemically. Both pharmacological inhib-
ition and genetic knockout of TRPV1 has been shown to
prevent bone loss in ovariectomized mice [25]. Capsaici-
noids are also known to consistently improve glycemic
control, although their effects on insulin secretion have
been controversial [23,25]. However, since impaired glu-
cose tolerance and Alzheimer’s disease have a common
etiological pathway, red pepper and its components might
be beneficial for protecting against Alzheimer’s diseases.
There are various types of red peppers according to the
different combinations of bioactive components (capsa-
icin, capsaicinoids and flavonoids) which give the peppers
various colors and pungencies [26]. Furthermore, red
peppers with different colors and pungencies differently
modulate energy and glucose homeostasis in OVX rats
fed high fat diets [27]. Therefore, we hypothesized that
specific varieties of red peppers might have a beneficial
effect on preventing cognitive dysfunction and insulin
resistance in type 2 diabetic rats with experimentally in-
duced Alzheimer’s-type dementia. The objective of this
study was to test the hypothesis using three varieties of
red pepper from Young Yang County (Gungsangbuk-Do,
Korea) according to the intensity of pungency: mild pun-
gency red pepper (Geumdang, 1500 Scoville heat units),
moderate pungency red pepper (Chilsung, 4000 Scoville
heat units) and severe pungency red pepper (Subicho,
10,000 Scoville heat units) in partially pancretectomized
rats, and also to explore possible mechanisms.Materials and methods
Extraction and lyophilization
Three varieties of red pepper powders (mild, moderate and
severe pungencies) were extracted with 70% ethanol by
shaking for 24 h at 25°C, centrifuged at 8,000 × g for
30 min, and its supernatants were collected and superna-
tants lyophilized in a freeze-drier (Il Shin, Dongdochun-Si,
Korea). Extraction using 70% ethanol is a very common ex-
traction method for herbal preparations [28]. This method
allows for the efficient extraction of many polar and non-
polar compounds and is an efficient method for concen-
trating a wide variety of bioactive compounds including
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out risk of toxic residue.
Animals and diets
Male Sprague Dawley rats, weighing 192 ± 30 g, were
housed individually in stainless steel cages in a controlled
environment (23°C and a 12 hour light/dark cycle). All ex-
perimental procedures were performed according to the
guidelines and with the approval of the Animal Care and
Use Review Committee at Hoseo University, Korea. The
rats had a 90% pancreatectomy (Px) using the Hosokawa
technique and Px rats included in the experiments showed
characteristics of type 2 diabetes after 2 weeks post-
surgery [29]. Since the pancreas partially regenerates (to
about 40% of the original volume) this technique results
in a diminished insulin secretory capacity and inability to
compensate for insulin resistance as typically seen in the
Asian population.
After 7 days post Px surgery, rats were anesthetized
with an intraperitoneal injection of a ketamine and xyla-
zine mixture (100 mg and 10 mg/kg body weight, re-
spectively) and placed in a stereotaxic device. A stainless
steel cannula was implanted to stereotaxically connect
an osmotic pump to the cannula implanted into the
bilateral CA1 subregion using the following coordinates:
lateral, −3.3 mm from the bregma; posterior, 2.0 mm
from the midline; ventral, −2.5 mm from dura [30]. The
β-amyloid (25–35) for AD and (35–25) for Non-AD
were dissolved in sterile saline and infused into the can-
nula secured in bilateral CA1 subregions of the hippo-
campus using an osmotic pump (Alzet Osmotic Pump
Company, Cupertino, CA, USA) at the rate of 3.6 nmol/
day for 14 days. The β-amyloid (35–25) had the reverse
sequence of β-amyloid (25–35) and does not accumu-
late in the brain and is not detected by immunohisto-
chemistry (normal-control).
Px rats infused with β-amyloid (25–35) were randomly
assigned to four different groups of 20 animals each fed
Western diets with elevated dietary fat to induce insulin
resistance and supplemented with either 1% dextrin (AD-
CON) or 1% of either mild pungency red pepper extract
(AD-LP), moderate pungency red pepper extract (AD-
MP), or sever pungency red pepper (AD-SP). Px ratsFigure 1 Time table of the experimental studies. EU clamp, euglycemicinfused with β-amyloid (35–25) had Western diets con-
taining 1% dextrin as a normal control (Non-AD-CON).
The dosage of red pepper extracts used in the present
study is equivalent to approximately 3 g/day in humans
and was based on extrapolation from our previous capsa-
icin and capsiate studies [27,23]. All rats freely consumed
water and corresponding diets based on AIN-93 diet [31]
for 47 days. All diets consisted of approximately 40 energy
percent (En%) carbohydrates, 20 En% protein, and 40 En%
fats. The major carbohydrate, protein and fat sources were
starch plus sugar, casein (milk protein), and lard (CJ Co.,
Seoul). Figure 1 shows a time table of the experiments in
the present study.
Serum glucose levels, food intakes, and body weights
were measured weekly after overnight feed-deprivation.
Homeostasis model assessment for insulin resistance index
(HOMA-IR) was calculated as serum insulin levels (μU) ×
serum glucose levels (mM)/22.5.Energy expenditure by indirect calorimetry
After 39 days of the assigned treatment, energy expend-
iture was assessed at the beginning of the dark phase of
the light–dark cycle after 6 h of feed-deprivation. The rats
were placed into metabolic chambers (airflow = 800 ml/
min) equipped with a computer-controlled O2 and CO2
measurement system (Biopac Systems Inc., Goleta, CA).
The respiratory quotient (RQ) and resting energy expend-
iture (REE) were calculated using the equations provided
by Niwa et al. [32]. Average oxygen consumption (VO2)
and average carbon dioxide production (VCO2) were cal-
culated using previously published methods and used to
calculate carbohydrate and fat oxidation and the amount
of oxygen consumed per gram of substrate oxidized [27].Locomotive activity
Locomotive activity was determined using a Linton
AM1053 Activity Monitor consisting of a three-dimensional
array of infrared beams placed around clear Perspex cages
with AmLogger software (Linton Instruments, UK). The
sum of rearing, mobility and activity measurements was
used as a measure of total locomotive activity. Activity
was assessed for 1 h during the dark phase of the light/hyperinsulinemic clamp; HG clamp, hyperglycemic clamp.
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30 min to adapt to a clear Perspex cage.
Passive avoidance test
On day 42 of the study, the rats were tested for short-
term memory deficits using a passive avoidance appar-
atus consisting of a two-compartment dark/light shuttle
box [30]. In the acquisition trial, electroshocks (75 V,
0.2 mA, 50 Hz) were delivered for 5 s, immediately after
a rat had entered the dark chamber. Five seconds later,
the rat was removed from the dark chamber and returned
to its home cage. After 24 h, the retention latency time
was measured in the same way as in the acquisition trial
but electric foot shock was not delivered and the latency
time was recorded to a maximum of 600 s. Short laten-
cies indicate memory deficit, compared to significantly
longer latencies.
Water maze test
Spatial memory function was assessed with a Morris water
maze test, as previously described [30], during day 44. The
Morris water maze tests hippocampal-dependent learning,
including the acquisition of spatial memory, long-term
memory, and long-term spatial memory.
Euglycemic hyperinsulinemic clamp
After catheterisation of the right carotid artery and left
jugular vein in the 7th week, 10 rats were randomly
selected and they were subjected to a euglycemic hyper-
insulinemic clamp in a fasted conscious state (n = 10)
to determine insulin resistance as previously described
[23,33]. [3-3H] glucose (Perkin Elmer, Wellesley, MA)
was continuously infused during a four-hour period at
the rate of 0.05 μCi/min. Basal hepatic glucose output
was measured in blood collected at 100 and 120 minutes
after initiation of the (3-3H) glucose infusion. A primed
continuous infusion of human regular insulin (Humulin;
Eli Lilly, Indianapolis, IN) was then initiated at a rate of
20 pmol/kg bw/min to raise plasma insulin concentration
to approximately 1100 pM after 210–240 min. Blood sam-
ples were collected at 10-minute intervals and 25% glu-
cose was infused as needed to clamp glucose levels at
approximately 6 mM. Rates of whole body glucose uptake
and basal glucose turnover were determined according to
the ratio of the [3-3H] glucose infusion rate to the specific
activity of plasma glucose (dpm/mmol) during the final
30 minutes. Hepatic glucose production at the hyperinsu-
linemic clamped state was determined by subtracting the
glucose infusion rate from the whole body glucose uptake.
Hyperglycemic clamp
After seven weeks of treatment, catheters were im-
planted into the right carotid artery and left jugular vein
of the remaining ten rats from each group as previouslydescribed [23,34]. At 5–6 days after implantation, a hyper-
glycemic clamp to determine insulin secretory capacity
was performed in free-moving and overnight fasted rats.
During the clamp, glucose infusion maintained serum
glucose levels at 5.5 mM above the baseline and serum
insulin levels were measured at 0, 2, 5, 10, 60, 90 and
120 min. Two days after the clamp, food-deprived rats
were injected with human regular insulin (5 U/kg body
weight) through the inferior vena cava. Ten min later, they
were killed by decapitation, tissues collected and frozen in
liquid nitrogen, and stored at −70°C. Liver glycogen con-
tent was determined after centrifuging lysates at 3000 rpm
for 10 minutes and deproteinizing the supernatants with
1.5 N perchloric acid. The glycogen content was calcu-
lated from glucose released from glycogen hydrolyzed by
α-amyloglucosidase in an acid buffer [27,35]. Serum insu-
lin levels were measured using a rat ELISA kit (Linco).
Triglyceride was extracted with chloroform-methanol (2:1,
vol/vol) from the liver and resuspended in pure chloro-
form and determined as previously described [27,35] using
a Trinder kit (Young Dong Pharm., Seoul, Korea).
Brain and islet immunohistochemistry
The day after hyperglycemic clamp, overnight-fasted five
rats were randomly selected from 10 rats of each group
and were injected with BrdU (100 μg/kg body weight). Six
hours post-injection, rats were anesthetized with intraperi-
toneal injections of a mixture of ketamine and xylazine,
and the brain and pancreas was immediately dissected,
perfused with saline and a 4% paraformaldehyde solution
(pH 7.2) sequentially and postfixed with the same fixative
overnight at room temperature [23,30].
Cryoprotected brain frozen tissues were serially sec-
tioned on a cryostat (Leica, Wetzlar, Germany) into 30 μm
coronal sections and β-amyloid accumulation in the hippo-
campus was determined by immunohistochemistry using
β-amyloid antibody [30]. The β-amyloid deposition was
calculated as the % β-amyloid-positive cells in the hippo-
campus area When sectioning paraffin-embedded pancre-
atic tissues, two of the 5-μm sections were discarded
between each saved section to avoid duplicate analysis of
the same islets when measuring the β-cell area, BrdU
incorporation, and apoptosis were assessed as described
previously using an immunohistochemistry method [23].
Pancreatic β-cell mass was estimated by multiplying the
percentage of insulin-positive area by the weight of pancre-
atic tissues. The individual β-cell size was determined as
the insulin-positive area divided by the number of nuclei
counted in the corresponding insulin-positive structures in
randomly immunofluoresence-stained sections using insu-
lin antibody. BrdU incorporation in β-cells was determined
with anti-insulin and anti-BrdU antibodies (R&D System,
Minneapolis, MN) and β-cell proliferation was calculated
as the total BrdU+ nuclei in β-cell nuclei per pancreas
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TUNEL kit (Roche Molecular Biochemicals, Indianapo-
lis, IN) and counterstained with hematoxylin and eosin
to visualize islets and apoptotic β-cells were measured
by the total number of apoptotic bodies in β-cell nuclei
per pancreas section.
Immunoblot analysis
The day after hyperglycemic clamp, four overnight-
fasted rats were randomly selected from 10 rats of each
group and the hippocampi from the four rats were iso-
lated. They were lysed in 20 mM Tris buffer (pH 7.4)
containing 2 mM EDTA, 137 mM NaCl, 1% NP40, 10%
glycerol and 12 mM α-glycerol phosphate and protease
inhibitors. After 30 min on ice, the lysates were centri-
fuged for 10 min at 12,000 rpm at 4°C. After measuring
protein contents in lysates using a Bio-Rad protein assay
kit, lysates with equal amounts of protein were immu-
noprecipitated with specific antibodies prior to separ-
ation by SDS-PAGE as previously described [23,30].
Antibodies used for the immunoblot analysis were
cAMP responding element binding protein (CREB),
phosphorylated CREBser133, protein kinase B (PKB or
Akt), phosphorylated PKBSer473, glycogen synthase kinase
(GSK)-3β, phosphorylated GSK-3βser9, tau, phophorylated
tauser396 and β-actin (Cell Signaling Technology). The in-
tensity of protein expression was determined using Image-
quant TL (Amersham Biosciences).
Statistical analysis
All results were expressed as a mean ± SD. Statistical
analyses were performed using SAS version 7 (SAS Insti-
tute). All variables exhibited normal distribution in uni-
variate analysis. One-way ANOVA was used to
determine animal group effects separately for each time
point and each treatment. Differences among groups
with a P < 0.05 were considered statistically significant
by Tukey’s test.
Results
Hippocampal β-amyloid deposition and cognitive function
The β-amyloid (25–35) immunoreactivities of the hippo-
campi were markedly greater in AD-CON compared to
Non-AD-CON, and the immunostaining was decreased
in descending order of LP <MP < SP < CON in the β-
amyloid infused diabetic rats (Figure 2).
In the passive avoidance test, AD-C had a shorter reten-
tion time to enter the lighted room than Non-AD-CON
despite previous experience of electric shock upon enter-
ing the light room. This indicated that AD-C had impaired
short-term memory in comparison to Non-AD-CON. The
retention time was made longer with SP =MP < LP <
CON in the β-amyloid infused diabetic rats (Figure 3A).
In addition, the water maze test revealed that the rats ofthe Non-AD-CON group swam across the pool and
quickly reached the platform, rapidly learning its loca-
tion, but the rats of the AD-CON took a significantly
longer retention time to locate the platform at zone 5 and
were in zone five for a shorter time (Figure 3B). Rats in the
LP < SP <MP groups found zone 5 locating the platform
faster than AD-CON and rats in the AD-CON< LP <MP
and SP stayed in zone 5 longer (Figure 3B). Thus, AD-
CON infused with β-amyloid (25–35) experienced a de-
cline in short term and spatial memory, which was fully
or partially prevented by MP = SP > LP.Hippocampal insulin signaling
The phosphorylation of CREB increased with MP and
SP in AD rats in comparison to the control group. As an
indicator of insulin signaling, the phosphorylation of Akt
was also higher in LP, MP, and SP than the control groups
and the increment for MSP was highest among all groups
(Figure 4). The phosphorylation of GSK-3β, a downstream
of GSK, exhibited the same pattern of phosphorylation as
Akt. The phosphorylation of tau was lower in descending
order of control > LP >MP and SP. Therefore, MP and
SP consumption prevented the attenuation of hippo-
campal insulin signaling and the prevention resulted in
lower tau phosphorylation.Energy metabolism
In diabetic rats AD-CON tended to have lower body
weight than Non-AD-CON, but it was not significantly
different. Rats in the LP and SP groups did not change
body weight in comparison to AD-CON but MP some-
what increased up to those of the Non-AD-CON group.
However, epididymal and retroperitoneal fat mass rela-
tive to body weight were significantly higher in the AD-
CON group than the Non-AD-CON group. LP, MP and
SP supplementations all resulted in fat masses similar to
the Non-AD-CON group (Table 1). Energy intake tended
to be lower in the AD-CON compared to the Non-AD-
CON rats, but LP, MP and SP prevented its decrease in
AD rats. However, locomotive activity was decreased in
AD-CON rats and MP and SP inhibited the decrease.
Daily energy expenditure was not different between AD-
CON and Non-AD-CON and oxygen consumption and
respiratory quotient were not different among the groups.
However, SP increased oxygen consumption and daily
energy expenditure in comparison to AD-CON but re-
spiratory quotient was not significantly different among
the groups. Carbohydrate oxidation was greater and fat
oxidation lower in the AD-CON group compared to the
Non-AD-CON. MP and SP reversed these differences in
energy nutrient oxidation in AD rats, and AD rats given
MP and SP had greater fat oxidation more than Non-
AD-CON rats.
Figure 2 β-amyloid staining in the hippocampus. At the end of experimental period, the brain section (30 μm) was stained for β-amyloid
using immunohistochemical techniques. The β-amyloid positive cells were counted in the hippocampus area. The β-amyloid (25–35) infused
diabetic rats fed high fat diets with 1% dextrin (AD-CON), 1% less pungent red pepper (AD-LSP), moderate pungent red pepper (AD-MSP) or
severe pungent red pepper (AD-SSP) for 28 days. The β-amyloid (35–25) infused rats fed high fat diets with 1% dextrin (Non-AD-CON). Each bar
represents Means ± SD (n = 5). abcdDifferent letters on the bars indicate significant differences at P < 0.05.
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In comparison with Non-AD-CON rats, AD-CON rats
displayed decreased glucose infusion rates by about 29%
at hyperinsulinemic clamped states (about 1100 pM serum
insulin levels). However, the decrease in AD rats was pre-
vented by LP, MP and SP treatments (Figure 5A). Hepatic
glucose output in the basal state was not significantly
different between AD-CON and Non-AD-CON rats and
none of the treatments altered it in AD rats (Figure 5B).
However, hepatic glucose output at the hyperinsuline-
mic state was higher in AD-CON than Non-AD-CON,
but it was suppressed by LP <MP = SP in AD-rats. Since
glucose uptake was not significantly different among the
groups, a good portion of the difference in glucose
infusion rates could be accounted for by the insulin-
stimulated decreases in hepatic glucose production.
This indicated that the exacerbation of insulin resist-
ance in the AD-CON group was mainly associated with
hepatic insulin resistance.Insulin secretion capacity
Serum glucose levels in the overnight fasted state did
not differ between AD-CON and Non-AD-CON rats and
the treatment with red pepper extracts did not alter the
levels in AD rats. However, overnight fasted serum insulin
levels were higher in the AD-CON group than Non-AD-
CON whereas they were lower in rats fed LP, MP and SP.
When calculating insulin resistance from serum glucose
and insulin levels at the fasted state, it was higher in the
AD-CON group than the Non-AD-CON group and all of
the treatments lowered it to similar levels as Non-AD-
CON (Table 1).
To confirm the above observations, hyperglycemic
clamp was performed on rats in all groups. During hyper-
glycemic clamp was used to determine β-cell function, in-
sulin secretion was biphasic, with a first and second
phase. In the first phase, plasma insulin levels peaked be-
tween 2 and 5 min in an acute state and then declined to
a nadir at 10 min. An ascending second phase of plasma
Figure 3 Memory, cognitive function and behavior changes of rats with β-amyloid infusion. Latency time to enter the dark room in
passive avoidance test (A) and the latency to locate zone with the platform during (B) and the period to stay in the platform zone on day 5
during water maze test (C) were given. The β-amyloid (25–35) infused diabetic rats fed high fat diets with 1% dextrin (AD-CON), 1% less pungent
red pepper (AD-LSP), moderate pungent red pepper (AD-MSP) or severe pungent red pepper (AD-SSP) for 28 days. The β-amyloid (35–25) infused
rats fed high fat diets with 1% dextrin (Non-AD-CON). Each dot and bar represents Means ± SD (n = 20). abcdDifferent letters on the bars indicate
significant differences at P < 0.05.
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90–120 min (Figure 6). Average and AUC of serum insulin
levels were higher in AD-CON rats in the first and second
phases of insulin secretion than those of Non-AD-CON
rats (Table 2). LP, MP and SP treatments resulted in simi-
lar serum insulin levels at the first phase as the AD-CON
group (Table 2). However, all of treatments inhibited the
increase in insulin secretion at the second phase. Thus,
this suggests that LP, MP and SP prevented rampant insu-
lin secretion during the second phase in AD rats without
suppressing the first phase insulin secretion.
Glucose infusion rates in hyperglycemic clamp indi-
cated β-cell function and insulin sensitivity at the hyper-
glycemic state, calculated as the ratio of glucose infusion
rates to steady-state serum insulin levels [23,33]. Glucose
infusion rates required to maintain hyperglycemia at
5.5 mM above baseline were found to be greater in the
descending order of the MP = SP < LP = control groups
(Table 2). Insulin sensitivity at the hyperglycemic state
was lower in AD-CON than Non-AD-CON whereas it
was enhanced in the ascending order of control < LP =
MP < SP in AD-CON rats. SP showed a comparable in-
sulin sensitivity to Non-AD-CON at the hyperglycemic
state (Table 2). Therefore, AD-CON exhibited disrupted
regulation of insulin secretion and attenuated insulin
sensitivity at the hyperglycemic state in comparison to
the Non-AD-CON, but LP, MP and SP prevented the
disruption of insulin secretion and insulin resistance and
was similar to Non-AD-CON.Pancreatic β-cell mass, proliferation and apoptosis
Pancreatic β-cell area was estimated from the combin-
ation of the number and size of β-cells. The percentage
of β-cell area was significantly lower in AD-CON rats
than Non-AD-CON rats, whereas LP treatment in AD
rats increased the area (Table 3). Individual β-cell size,
indicating β-cell hypertrophy, was higher in AD-CON
rats than in Non-AD-CON rats and LP and MP in AD
rats lowered them to a similar size as the Non-AD-CON
size. However, pancreatic β-cell mass, calculated by multi-
plying β-cell area by the pancreas weight was significantly
lower in the AD-CON than the Non-AD-CON group,
whereas LP and MP increased total β-cell mass signifi-
cantly, to as much as the Non-AD-CON (Table 3). Islet
morphometry revealed that proliferation of β-cells was
not significantly different between AD-CON and Non-
AD-CON groups and none of the treatments with red
pepper extracts altered β-cell proliferation (Table 3). In
contrast, AD-CON rats had elevated β-cell apoptosis com-
pared to Non-AD-CON rats and the elevation was sup-
pressed by LP, MP and SP treatments (Table 3).
Discussion
Red pepper is known to prevent obesity by increasing
energy expenditure and improving glucose homeostasis
[26,27]. Furthermore, red pepper types with different pun-
gencies have been shown to differently affect energy and
glucose homeostasis in ovariectomized rats [27]. This is
related to the contents of capsaicinoids, total flavonoids
Figure 4 Insulin signaling in the hippocampus. The β-amyloid
(25–35) infused diabetic rats fed high fat diets with 1% dextrin
(AD-CON), 1% less pungent red pepper (AD-LSP), moderate pungent
red pepper (AD-MSP) or severe pungent red pepper (AD-SSP) for
28 days. The β-amyloid (35–25) infused rats fed high fat diets with
1% dextrin (Non-AD-CON). CREB, cAMP responding element binding
protein; pCREB, phosphorylated CREB; Akt, protein kinase B; pAKT,
phosphorylated Akt; GSK, glycongen synthase kinase; pGSK,
phosproylated GSK; Tau, tau protein; pTau, phosphorylated Tau
protein. Each bar represents Means ± SD (n = 4). abcdDifferent letters
on the bars indicate significant differences at P < 0.05.
Table 1 Body weight visceral fat contents and overnight-faste
experimental periods
AD-CON (n = 20) AD-LSP (n
Body weight (g) 320 ± 33b 317 ± 29b
Epididymal fat pads/body weight (g/kg bw) 9.0 ± 1.2a 7.1 ± 0.9b
Retroperitoneal fat/body weight (g/kg bw) 15.5 ± 2.0a 12.4 ± 1.9
Energy intake (kcal/day) 105 ± 17 114 ± 15
Total active time (m/h) 4.4 ± 0.7b 5.2 ± 0.8ab
Energy expenditure (kcal/kg0.75/day) 119 ± 15b 126 ± 15a
Respiratory quotient 0.86 ± 0.11 0.84 ± 0.1
VO2 (mL/kg
0.75/min) 17.0 ± 2.1b 17.9 ± 2.2
Carbohydrate oxidation (mg/kg0.75/min) 6.6 ± 0.9a 6.1 ± 0.7ab
Fat oxidation (mg/kg0.75/min) 6.1 ± 0.8c 7.3 ± 0.9b
Values are mean ± SD. The β-amyloid (25–35) infused diabetic rats fed high fat diet
pungent red pepper (AD-MSP) or severely pungent red pepper (AD-SSP) for 28 day
dextrin (Non-AD-CON).
abcDifferent superscript alphabets on the same row indicate significant differences a
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vealed that the contents of total capsaicinoids were higher
in the descending order of SP, MP and LP whereas those
of total flavonoids and total phenolic compounds were
higher in ascending order of SP, LP and MP [27]. The
present study showed that the efficacies of the extracts
were: control < LP <MP and SP for preventing memory
deficit and for decreasing β-amyloid accumulation in the
hippocampus through potentiating pCREB➔pGSK and
lowering pTau. In addition, the red pepper extracts im-
proved hepatic insulin sensitivity in rats with Alzheimer’s
like symptoms. Insulin secretion especially as measured in
the second phase was greater in AD rats than Non-AD
rats and LP, MP and SP lowered it. Β-cell mass was lower
in AD rats due to increased β-cell apoptosis than Non-AD
rats and all red pepper extracts prevented the decrease.
These results demonstrate that MSP and SSP can prevent
both the cognitive dysfunction and hepatic insulin resist-
ance exhibited by this animal model of type 2 diabetic rats
with experimentally induced AD.
The pathogenesis of Alzheimer’s disease is not yet fully
understood. However, the formation of β-amyloid plaques
play a crucial a role in Alzheimer’s diseases in humans. β-
amyloid infusion into the lateral ventricle or CA1 region
in the hippocampus of animals also induces hyperpho-
sphorylated tau aggregates, neurofibrillary tangles and
concomitant cognitive dysfunction [30,36]. These animals
exhibit similar characteristics to those of humans with
Alzheimer’s diseases. The symptoms are associated with
the hyperphosphorylation of tau, a key factor in the
formation of neurofibrilary tangles [8,37]. The hyperpho-
sphorylation is associated with brain insulin resistance
that results from the impairment of several pathways such
as insulin and IGF-1 signaling [18,37,38]. IGF-1 and insu-
lin signaling are connected to CREB phosphorylation ind serum glucose and insulin levels at the end of
= 20) AD-MSP (n = 20) AD-SSP (n = 20) Non-AD-CON (n = 20)
333 ± 34ab 322 ± 30b 348 ± 31a
7.4 ± 1.0b 7.2 ± 0.9b 7.5 ± 1.0b
b 13.2 ± 1.9b 12.5 ± 1.8b 12.9 ± 1.8b
119 ± 21 118 ± 19 113 ± 14
5.7 ± 0.8a 5.4 ± 0.6a 5.5 ± 0.6a
b 129 ± 16ab 133 ± 16a 111 ± 14b
0 0.81 ± 0.10 0.80 ± 0.09 0.83 ± 0.10
ab 18.4 ± 2.2ab 19.0 ± 2.1a 15.9 ± 2.0b
4.8 ± 0.6b 5.0 ± 0.6b 4.8 ± 0.6b
8.9 ± 1.1a 9.2 ± 1.1a 7.1 ± 0.9b
s with 1% dextrin (AD-CON), 1% less pungent red pepper (AD-LSP), moderately
s. The β-amyloid (35–25) infused rats fed high fat diets with 1%
t P < 0.05.
Figure 5 Glucose infusion rates and hepatic glucose output during a euglycemic hyperinsulinemic clamp. Euglycemic hyperinsulinemic
clamp was performed in conscious, free moving, and overnight fasted rats to determine whole body insulin resistance. Glucose infusion rates
and glucose uptake at a clamped steady-state (A) and hepatic glucose output at baseline and hyperinsulinemic state about 1100 pM of serum
insulin (B) were presented. The β-amyloid (25–35) infused diabetic rats fed high fat diets with 1% dextrin (AD-CON), 1% less pungent red pepper
(AD-LSP), moderate pungent red pepper (AD-MSP) or severe pungent red pepper (AD-SSP) for 28 days. The β-amyloid (35–25) infused rats
fed high fat diets with 1% dextrin (Non-AD-CON). Each bar represents Means ± SD (n = 10). abcDifferent letters on the bars indicate significant
differences at P < 0.05.
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press CREB, which is associated with memory function
and CREB phosphorylation plays a critical step for the ini-
tiation of learning and memory-required gene transcrip-
tion [39]. Since the activation of TRPV1 also potentiates
the phosphorylation of CREB that increases the expression
of IRS2 especially in the liver and brain [40], TRPV1 acti-
vation may enhance IGF-1 signaling. Furthermore, several
lines of scientific evidence supports that TRPV1 is in-
volved in cognitive function [41]. First of all, the TRPV1 is
widely expressed in the hippocampus [42]. Second, theFigure 6 Insulin secretion during a hyperglycemic clamp.
Hyperglycemic clamp was conducted in conscious, free moving,
and overnight fasted rats to measure glucose-stimulated insulin
secretion. As exogenous glucose was infused into jugular vein to
make approximately 5.5 mM above overnight fasted serum glucose
levels, serum insulin levels were measured at 0, 2, 5, 10, 30, 60, 90
and 120 mins. The β-amyloid (25–35) infused diabetic rats fed high
fat diets with 1% dextrin (AD-CON), 1% less pungent red pepper
(AD-LSP), moderate pungent red pepper (AD-MSP) or severe pungent
red pepper (AD-SSP) for 28 days. The β-amyloid (35–25) infused
rats fed high fat diets with 1% dextrin (Non-AD-CON). Each dot
represents Means ± SD (n = 10). *Significantly different among the
groups at P < 0.05.activation of TRPV1 increases the release of calcitonin
gene-related peptide (CGRP) from sensory and dorsal root
ganglion neurons dose-dependently [37,40]. CGRP is re-
ported to increase IGF-1 production in the astrocytes in
the hippocampus [43]. Thus, TRPV1 agonists such as cap-
saicin may prevent brain insulin resistance by the activa-
tion of insulin/IGF-1 signaling.
Red peppers contain many bioactive components such
as capsaicin, dihydrocapsaicin, β-carotene, zeaxanthin,
capsanthin, total carotenoids and chlorogenic acid [27].
The contents of capsaicin, dihydrocapsaicin and total
capsaicinoids were greater in an ascending order of mildly
pungent red pepper (Geumdang) <moderate (Chilsung) <
severe (Subicho) in our previous study [25]. This is related
to the amount of TRPV1 agonists with different pungency
such as capsaicin (pungent) and capsiate (non-pungent)
that have different activities for energy metabolism and
glucose homeostasis in diabetic rats [23]. Capsaicin and
capsiate have better activity for increasing energy metabol-
ism and glucose tolerance, respectively [23]. In addition,
severely pungent red pepper was shown to decrease fat
mass and increase energy expenditure better than less se-
vere pungent red pepper whereas less pungent red pepper
was more effective for improving insulin sensitivity and
hepatic insulin signaling [27]. Peppers differently affect en-
ergy balance and glucose homeostasis according to color
and pungency due to their different bioactive components.
The present study also found that pungency of red pepper
determined the effectiveness for improving cognitive func-
tion: capsaicin-rich red peppers such as MP and SP
improved cognitive function and potentiated hippocampal
IGF-1 and insulin signaling (pCREB ➔ pAkt ➔ pGSk-3b)
better that LP in the hippocampus. Capsaicin and dihy-
drocapsacin were apparently the major components that
enhanced cognitive function by decreasing β-amyloid ac-
cumulation, but their contents in MSP may be sufficient











Serum glucose at basal state (mM) 7.1 ± 0.8 6.9 ± 0.7 7.1 ± 0.7 7.0 ± 1.0 7.0 ± 0.6
Serum insulin (ng/mL) 1.37 ± 0.17a 1.13 ± 0.15b 1.07 ± 0.16b 1.05 ± 0.14b 1.09 ± 0.15b
HOMA-IR 12.6 ± 2.5a 9.4 ± 2.1b 9.1 ± 1.9b 8.8 ± 1.9b 9.2 ± 2.1b
First phase of insulin (0–10 min; ng/mL) 2.25 ± 0.35 2.18 ± 0.32 2.26 ± 0.33 2.44 ± 0.34 2.51 ± 0.37
Second phase of insulin (60–120 min; ng/mL) 2.66 ± 0.38a 2.42 ± 0.40ab 2.34 ± 0.34b 2.36 ± 0.32b 2.32 ± 0.34b
AUC of first phase of insulin (0–10 min; ng/mL*min) 26.3 ± 3.8 25.8 ± 3.5 26.7 ± 3.6 29.1 ± 3.6 30.0 ± 4.2
AUC of second phase of insulin (30–120 min; ng/mL*min) 246 ± 33a 225 ± 31ab 215 ± 29b 217 ± 27b 212 ± 28b
Glucose infusion rate (mg/kg bw/min) 8.6 ± 1.5c 11.6 ± 1.8b 12.8 ± 2.0ab 13.2 ± 2.1a 13.4 ± 1.9a
Insulin sensitivity at hyperglycemic state
(μmol glucose · min−1 · 100 g−1 per μmol insulin/L)
3.2 ± 0.6c 4.8 ± 0.7b 5.5 ± 0.8a 5.6 ± 0.8a 5.8 ± 0.8a
Values are Means ± SD. Values are mean ± SD. The β-amyloid (25–35) infused diabetic rats fed high fat diets with 1% dextrin (AD-CON), 1% less pungent red
pepper (AD-LSP), moderately pungent red pepper (AD-MSP) or severely pungent red pepper (AD-SSP) for 28 days. The β-amyloid (35–25) infused rats fed high fat
diets with 1% dextrin (Non-AD-CON). HOMA-IR, homeostatic model assessment for insulin resistance. First phase of serum insulin was defined as the average of
serum insulin levels at 2 and 5 mins, with second phase at 60, 90 and 120 mins. Insulin sensitivity at hyperglycemic state was calculated as the ratio of glucose
infusion rate to steady-state plasma insulin levels.
abcDifferent superscript alphabets on the same row indicate significant differences at P < 0.05.
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diet since MP and SP were equally effective for improving
cognitive function. Thus, the components that activate
TRPV1 may mitigate cognitive dysfunction through IGF-1
signaling in the hippocampus.
The deposition of β-amyloid in the brain induces brain
and possibly peripheral insulin resistance that is a com-
mon pathophysiological feature of Alzheimer’s diseases
and type 2 diabetes [11,44]. Alzheimer’s disease patients
also have impaired glucose regulation but the dysregula-
tion is not as severe as in type 2 diabetes [45], since glu-
cose homeostasis is a result of both insulin resistance
and insulin secretion. Type 2 diabetes is induced when in-
sulin secretion cannot compensate for insulin resistance.
However, many Alzheimer’s disease patients release suffi-
cient insulin to compensate for insulin resistance and do
not progress to type 2 diabetes [44]. The present study
found that β-amyloid deposition increased in the control
group and exacerbated peripheral insulin resistance
whereas MP and SP had fewer β-amyloid tangles and
better peripheral insulin sensitivity. Since capsaicin is
known to activate TRPV1 [46], and MP and SP containedTable 3 Islet morphometry
AD-CON (n = 5) AD-LSP (n
β-cell area (%) 5.3 ± 1.1b 6.4 ± 0.9b
Individual β-cell size (μm2) 261 ± 30a 228 ± 29b
Absolute β-cell mass (mg) 21.0 ± 3.1b 24.7 ± 2.9a
BrdU+ cells (% BrdU+ cells of islets) 0.94 ± 0.13 1.03 ± 0.12
Apoptosis (% apoptotic bodies of islets) 1.19 ± 0.16a 0.97 ± 0.12
Values are Means ± SD. The β-amyloid (25–35) infused diabetic rats fed high fat die
pungent red pepper (AD-MSP) or severely pungent red pepper (AD-SSP) for 28 day
dextrin (Non-AD-CON).
abDifferent superscript alphabets on the same row indicate significant differences amore capsaicin than LP, the former might activate the
TRPV1 more than the latter. The activation of TRPV1
probably decreased β-amyloid plaques by inhibiting tau
phosphorylation and it may be associated with decreasing
peripheral insulin resistance. Since LSP improved glucose
homeostasis better than MSP and SSP in ovariectomized
rats fed a high fat diet in our previous study [27], the
enhancement of glucose homeostasis by MP and SP in β-
amyloid infused rats was due to the decrease in β-amyloid
deposition in the hippocampus that exacerbated insulin
resistance in the present study. Thus, these results sug-
gested that the consumption of MP and SP resulted in the
lower β-amyloid deposition in the hippocampus and the
decrease prevented insulin resistance.
The brain plays an important role in regulating glu-
cose homeostasis. The brain and peripheral tissues, espe-
cially the liver and islets, are connected and reciprocally
deliver messages [47,48]. It is well-known that the hypo-
thalamus is a crucial organ in the regulation energy and
glucose metabolism. The hippocampus is a brain region
where neurogenesis continues throughout life and its
neuronal death results in altered neuronal circuits and= 5) AD-MSP (n = 5) AD-SSP (n = 5) Non-AD-CON (n = 5)
5.9 ± 0.8ab 5.7 ± 1.0ab 7.9 ± 1.0a
235 ± 28b 241 ± 27ab 234 ± 27b
24.0 ± 2.9a 23.5 ± 2.8ab 24.9 ± 2.9a
1.05 ± 0.11 1.06 ± 0.12 1.01 ± 0.14
b 1.02 ± 0.12b 1.02 ± 0.13b 0.95 ± 0.13b
ts with 1% dextrin (AD-CON), 1% less pungent red pepper (AD-LSP), moderately
s. The β-amyloid (35–25) infused rats fed high fat diets with 1%
t P < 0.05.
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brain, especially the hippocampus, ameliorates cognitive
dysfunction by insulin and Wnt signaling [48,49]. There-
fore, neuronal loss in the hippocampus due to β-amyloid
deposition might induce glucose dysregulation by ex-
acerbating peripheral insulin resistance, especially in the
liver. Furthermore, plasma β-amyloid (40/42) levels are
increased in Alzheimer’s disease patients with hypergly-
cemia and they exacerbate hepatic insulin resistance by
activating Janus kinase-2 signaling in the liver [50]. The
present study showed that MP and SP prevented the path-
way to cognitive dysfunction and hepatic insulin resistance
in rats induced cognitive dysfunction by β-amyloid accu-
mulation in the hippocampus.
In addition to peripheral insulin resistance, brain path-
ologies associated with AD affect insulin secretion by
impeding the cross-talk between the brain and islets via
the sympathetic nervous system and adipokines [30,44,51].
The accumulation of β-amyloid did not exacerbate the first
phase of glucose tolerance possibly due to a slight increase
in insulin secretion, but serum glucose levels during the
second phase reached a higher peak and decreased slowly,
indicating severe glucose intolerance and insulin resistance
[30,44]. Hyperglycemic clamp demonstrated that the insu-
lin secretion during 10–60 min was higher in β-amyloid in-
fused rats, but the insulin secretion during 60–120 min
decreased [44]. MP and SP protected against the higher
glucose levels during 10–60 min and the insulin secretion
of the second phase was maintained. These results indicate
that hippocampal β-amyloid deposition associated with
cognitive dysfunction might impair also the control of in-
sulin secretion by disrupting the tight regulation of insulin
secretion regardless of insulin resistance. β-cell function is
related to β-cell mass [23,51]. When insulin secretion is
not tightly regulated due to a certain condition such as in-
sulin resistance, β-cell size is increased but the number of
β-cells is not elevated [23]. As a result, β-cell mass is even-
tually decreased in an insulin resistant state. In addition,
insulin secretory capacity is markedly decreased when β-
cell mass is decreased due to increased β-cell apoptosis
and/or lowered β-cell proliferation [23]. The present study
demonstrated that β-cell mass was decreased resulting in a
lower maximal insulin secretion due to increased β-cell
apoptosis, but MSP and SSP protected against the impair-
ment of β-cell function and loss of mass. However, mice
lacking TRPV1 had a more youthful metabolic profile due
at least in part to greater maximal insulin secretion due to
greater β-cell mass as a consequence of less apoptosis [43].
These results appear contradictory to the present study,
and are similar to our previous study with long-term
consumption of capsaicin [23,27]. However, long-term cap-
saicin consumption may desensitize the TRPV1. Further
studies need to determine whether long-term consumption
of capsaicin activates or desensitizes the TRPV1.Conclusions
Hippocampal β-amyloid accumulation induced cognitive
dysfunction and impaired glucose homeostasis by ex-
acerbating insulin resistance and decreasing β-cell mass
in diabetic rats. MP and SP prevented the cognitive
dysfunction and glucose dysregulation better than LP.
These results suggest that capsaicin might be an effective
compound for improving both cognitive dysfuction and
hepatic insulin resistance. The results of this study may
not be fully applicable to humans since this study was
performed in rats infused with β-amyloid into the hippo-
campus and therefore does not replicate the etiology of
human Alzheimer’s disease, although it does closely re-
semble the pathological features of AD in humans.
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